Use of chimeras, point mutants, and molecular modeling to map the antagonist-binding site of 4,4',4″,4‴-(carbonylbis-(imino-5,1,3-benzenetriylbis(carbonylimino)))tetrakisbenzene-1,3-disulfonic acid (NF449) at P2X1 receptors for ATP.
about
Unique residues in the ATP gated human P2X7 receptor define a novel allosteric binding pocket for the selective antagonist AZ10606120.Medicinal chemistry of adenosine, P2Y and P2X receptors.Mechanistic insights from resolving ligand-dependent kinetics of conformational changes at ATP-gated P2X1R ion channels.The Molecular Determinants of Small-Molecule Ligand Binding at P2X Receptors.Mapping the Allosteric Action of Antagonists A740003 and A438079 Reveals a Role for the Left Flipper in Ligand Sensitivity at P2X7 Receptors.
P2860
Use of chimeras, point mutants, and molecular modeling to map the antagonist-binding site of 4,4',4″,4‴-(carbonylbis-(imino-5,1,3-benzenetriylbis(carbonylimino)))tetrakisbenzene-1,3-disulfonic acid (NF449) at P2X1 receptors for ATP.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Use of chimeras, point mutants ...... 49) at P2X1 receptors for ATP.
@en
type
label
Use of chimeras, point mutants ...... 49) at P2X1 receptors for ATP.
@en
prefLabel
Use of chimeras, point mutants ...... 49) at P2X1 receptors for ATP.
@en
P2860
P356
P1476
Use of chimeras, point mutants ...... 49) at P2X1 receptors for ATP.
@en
P2093
Louise K Farmer
Richard J Evans
P2860
P304
P356
10.1074/JBC.M114.592246
P407
P50
P577
2014-11-25T00:00:00Z